Surgalign Holdings, Inc. (SRGA)
Market Cap | 22.07M |
Revenue (ttm) | 83.24M |
Net Income (ttm) | -60.86M |
Shares Out | 12.76M |
EPS (ttm) | -13.12 |
PE Ratio | n/a |
Forward PE | 526.32 |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 82,252 |
Open | 1.64 |
Previous Close | 1.66 |
Day's Range | 1.61 - 1.80 |
52-Week Range | 1.34 - 9.30 |
Beta | 1.78 |
Analysts | Buy |
Price Target | 4.34 (+148.0%) |
Earnings Date | May 9, 2023 |
About SRGA
Surgalign Holdings, Inc., a medical technology company, develops, manufactures, distributes, and markets spine implants worldwide. It offers products for thoracolumbar procedures, including Streamline TL Spinal Fixation system, a system for degenerative and complex spine procedures; and Streamline MIS Spinal Fixation system, a range of implants and instruments used via a percutaneous or mini-open approach; and interbody fusion devices, as well as products for cervical procedures, such as CervAlign ACP system, a comprehensive anterior cervical p... [Read more]
Financial Performance
In 2021, SRGA's revenue was $90.50 million, a decrease of -11.06% compared to the previous year's $101.75 million. Losses were -$84.65 million, 150.6% more than in 2020.
Financial StatementsAnalyst Forecast
According to 8 analysts, the average rating for SRGA stock is "Buy." The 12-month stock price forecast is $4.34, which is an increase of 148.00% from the latest price.
News

Surgalign Holdings, Inc. Announces Fourth Quarter and Full Year 2022 Results
DEERFIELD, Ill., March 30, 2023 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of d...

Surgalign Schedules Fourth Quarter and Full Year 2022 Earnings Release for March 30, 2023
DEERFIELD, Ill., March 21, 2023 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of d...

Surgalign to Host its 2023 Annual Meeting of Shareholders on June 1, 2023
DEERFIELD, Ill., March 16, 2023 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of ...

Surgalign Provides Update on Corporate Restructuring Initiatives and Confirms its Prior 2022 Revenue Guidance
Company on track to achieve target cash savings of $30 - $35 million in 2023 vs 2022; expects to report 2022 revenue of approximately $82.0 million and end the year with a cash balance in excess of $1...

Surgalign to Participate at the 2023 AAOS Annual Meeting OrthoDome in Las Vegas
Dr. Rick C. Sasso, renowned spinal surgeon to highlight Surgalign's HOLO Portal™ Surgical Guidance System on the OrthoDome Panel on March 8, 2023 Dr. Rick C. Sasso, renowned spinal surgeon to highligh...

Xtant Medical Acquires Coflex® Product Line from Surgalign for $17 Million
Expands Xtant's Product Offering with the Leading PMA-Approved Intralaminar Stabilization Device

Surgalign Announces 100th Case Completed Utilizing its Recently Launched Cortera™ Spinal Fixation System
DEERFIELD, Ill., Dec. 15, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global medical technology company focused on elevating the standard of care by driving the evolution of di...

Surgalign Announces Closing of $12.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
DEERFIELD, Ill., Nov. 16, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global medical technology company focused on elevating the standard of care by driving the evolution of di...

Surgalign™ Announces Corporate Restructuring Program to Focus on Key Growth Areas
Company plans to realign in an effort to improve efficiencies, while lowering its capital requirements to invest in innovation; estimated cash savings in 2023 are expected to be approximately $30 - $3...

Surgalign Announces Third Quarter 2022 Results and Provides Update on Business Operations and Financial Outlook
DEERFIELD, Ill., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of di...

Surgalign Schedules Third Quarter 2022 Earnings Release for November 2, 2022
DEERFIELD, Ill., Oct. 25, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of di...

Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
DEERFIELD, Ill., Oct. 06, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (NASDAQ: SRGA), a global medical technology company focused on elevating the standard of care by driving the evolution of di...

Surgalign Launches Portfolio of Fortilink® with TiPlus™ Technology Products, Expanding its Addressable Market for Interbody Fusion Procedures
Broadens Fortilink interbody product line to now include both titanium and 3D-printed polymer options Broadens Fortilink interbody product line to now include both titanium and 3D-printed polymer opti...

Surgalign to Exhibit at the Society for Minimally Invasive Spine Surgery (“SMISS”) Annual Forum and the North American Spine Society (“NASS”) 2022 Annual Meeting
Company to showcase its HOLO Portal™ surgical guidance system for the first time at an industry event, with live, hands-on demonstrations from surgeons and medical professionals Company to showcase it...

Surgalign Announces FDA 510(k) Clearance of the Cortera™ Spinal Fixation System – The Company's New Flagship Posterior Fixation Platform
DEERFIELD, Ill., Aug. 24, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of di...

Surgalign Announces Global Settlement Agreement with Resolve Surgical Technologies and RTI Surgical, Inc.
Parties enter into new sole-source supply relationship, extended for two years Parties enter into new sole-source supply relationship, extended for two years

Surgalign Holdings, Inc. Announces Second Quarter 2022 Results and Reiterates Full Year 2022 Revenue Guidance Range
DEERFIELD, Ill., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of di...

Surgalign Names Paolo Amoruso Chief Legal Officer and Corporate Secretary
DEERFIELD, Ill., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of di...

Surgalign Reaches Settlement with the Securities and Exchange Commission on Matters Related to Prior Management Between 2015-2019
DEERFIELD, Ill., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) reached a settlement with the U.S. Securities and Exchange Commission (“SEC”) on August 3, 2022, concluding ...

Surgalign Announces the Commercial Relaunch of its Next Generation CervAlign Anterior Cervical Plate System Optimized for Discectomy and Fusion Procedures
DEERFIELD, Ill., July 20, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of di...

Surgalign Announces Partnership with PRIA Healthcare to Improve Patient Healthcare Coverage
Program to aid in patient access to Surgalign's Coflex® Interlaminar Stabilization® and SImmetry® SI Joint Fusion Systems

Here's Why Surgalign Holdings Shares Are Falling Today
Surgalign Holdings Inc (NASDAQ: SRGA) shares are trading lower by 19.73% at $0.15 after the company announced a 1-for-30 reverse stock split. The 1-for-30 reverse stock split will take effect at the o...

Surgalign Holdings, Inc. Announces 1-for-30 Reverse Stock Split
DEERFIELD, Ill., May 16, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of dig...

Surgalign Holdings, Inc. Announces First Quarter 2022 Results and Raises Full Year 2022 Revenue Guidance Range
DEERFIELD, Ill., May 10, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of dig...

Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
DEERFIELD, Ill., May 06, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (NASDAQ: SRGA), a global medical technology company focused on elevating the standard of care by driving the evolution of dig...